Weiss Multi-Strategy Advisers’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-26,573	Closed	-$234K	–	836
2021 Q1	$234K	Sell	26,573 -4,215	-14%	-$46.3K	0.01%	636
2020 Q4	$315K	Sell	30,788 -37,034	-55%	-$405K	0.01%	618
2020 Q3	$613K	Buy	67,822 +15,822	+30%	+$125K	0.02%	462
2020 Q2	$371K	Buy	52,000 +3,508	+7%	+$37.2K	0.01%	484
2020 Q1	$461K	Sell	48,492 -11,508	-19%	-$148K	0.02%	347
2019 Q4	$790K	Buy	+60,000	New	+$732K	0.01%	507

Other funds holding GRTX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Weiss Multi-Strategy Advisers's GRTX Position: Q2 2021 in Review

Weiss Multi-Strategy Advisers sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2021, closing a stake of 26,573 shares — an estimated $234K sold.

Weiss Multi-Strategy Advisers first reported a position in GRTX in Q4 2019 and held it in 6 quarters. The position peaked at $790K in Q4 2019. 47 funds tracked by Wall St. Rank hold GRTX as of Q2 2021.

Weiss Multi-Strategy Advisers reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 26,573 Galera Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $234K.
Weiss Multi-Strategy Advisers first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's Galera Therapeutics, Inc. Common Stock position peaked at $790K in Q4 2019.
47 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.